Overview

Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is a multicenter Phase III study to demonstrate the diagnostic utility of 124I-cG250 PET/CT pre-surgical imaging in patients with operable renal masses.
Phase:
Phase 3
Details
Lead Sponsor:
Heidelberg Pharma AG
Wilex
Treatments:
Antibodies
Cadexomer iodine
Iodine